Kenko Imalytics
Kenko Imalytics is a spin-off from the Universitat Politècnica de València (UPV) that develops cutting-edge biomarkers to aid in the clinical diagnosis of cancer, aiming to provide more time and life to oncology patients. Leveraging over ten years of research by its founding team, who are experts in statistical data and image analysis from the GIEM-UPV group, Kenko Imalytics has developed pioneering algorithms for the quantitative interpretation of MRI scans, shifting from the usual qualitative approach. Their technology focuses on improving the early diagnosis of breast and prostate cancer by calculating image biomarkers using statistical algorithms and machine learning models like PLS-DA. Their platform, Kenko Breast AI+, offers improved diagnostic accuracy, efficiency, speed, and quality by reducing false diagnoses and optimizing image processing time. They provide reliability information for their models and have received several awards as a startup.
Kenko Imalytics
Kenko Imalytics is a spin-off from the Universitat Politècnica de València (UPV) that develops cutting-edge biomarkers to aid in the clinical diagnosis of cancer, aiming to provide more time and life to oncology patients. Leveraging over ten years of research by its founding team, who are experts in statistical data and image analysis from the GIEM-UPV group, Kenko Imalytics has developed pioneering algorithms for the quantitative interpretation of MRI scans, shifting from the usual qualitative approach. Their technology focuses on improving the early diagnosis of breast and prostate cancer by calculating image biomarkers using statistical algorithms and machine learning models like PLS-DA. Their platform, Kenko Breast AI+, offers improved diagnostic accuracy, efficiency, speed, and quality by reducing false diagnoses and optimizing image processing time. They provide reliability information for their models and have received several awards as a startup.